rs 45041-190 has been researched along with Allodynia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Houghton, AK; Westlund, KN | 1 |
| Dillon, MP; Eglen, RM; Hedley, LR; Hunter, JC; Jett, MF | 1 |
2 other study(ies) available for rs 45041-190 and Allodynia
| Article | Year |
|---|---|
An I2 imidazoline ligand, RS 45041, potentiates hyperalgesia in acute arthritis.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Animals; Arthritis; Drug Evaluation, Preclinical; Drug Synergism; Hyperalgesia; Idazoxan; Imidazoles; Imidazoline Receptors; Indoles; Injections, Spinal; Isoindoles; Neural Inhibition; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Drug | 1996 |
Behavioral effects of RS-45041-190, a selective I2 imidazoline ligand, in rats.
Topics: Acetates; Amines; Analgesics; Animals; Carrageenan; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Hot Temperature; Hyperalgesia; Imidazoles; Imidazoline Receptors; Indoles; Injections, Intraperitoneal; Injections, Spinal; Isoindoles; Ligands; Male; Motor Activity; Pain; Rats; Rats, Sprague-Dawley; Receptors, Drug | 1999 |